CONCORD, Calif. & NEW YORK--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) and New York Blood Center (NYBC) announced today that they have entered into a research collaboration to explore the possibility of creating a red blood cell (RBC) biologic product with improved uniformity compared to a standard unit of red blood cells.
